Logo Logo

Publications by Pandha, H. S.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 3.

Journal article

Stähler, M.; Motzer, R. J.; George, D. J.; Pandha, H. S.; Donskov, F.; Escudier, B.; Kliment, J.; Pantuck, A. J.; Patel, A.; Deannuntis, L.; Bhattacharyya, H.; Lin, X.; Lechuga, M.; Serfass, L.; Patard, J.-J.; Ravaud, A. (2017): Adjuvant sunitinib (SU) in patients (pts) with high risk renal cell carcinoma (RCC): Safety and therapy management in S-TRAC trial. In: Annals of Oncology, Vol. 28

Ravaud, A.; Motzer, R. J.; Pandha, H. S.; George, D. J.; Pantuck, A. J.; Patel, A.; Chang, Y.-H.; Escudier, B.; Donskov, F.; Magheli, A.; Carteni, G.; Laguerre, B.; Tomczak, P.; Breza, J.; Gerletti, P.; Lechuga, M.; Lin, X.; Martini, J.-F.; Ramaswamy, K.; Casey, M.; Staehler, M.; Patard, J.-J. (2016): Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy. In: New England Journal of Medicine, Vol. 375, No. 23: pp. 2246-2254

Ravaud, A.; Motzer, R. J.; Pandha, H. S.; Staehler, M.; George, D.; Pantuck, A. J.; Patel, A.; Chang, Y.-H.; Escudier, B.; Donskov, F.; Magheli, A.; Carteni, G.; Laguerre, B.; Tomczak, P.; Breza, J.; Gerletti, P.; Lin, X.; Lechuga, M.; Martini, J.-F.; Patard, J.-J. (2016): Phase III trial of sunitinib (SU) vs placebo (PBO) as adjuvant treatment for high-risk renal cell carcinoma (RCC) after nephrectomy (S-TRAC). In: Annals of Oncology, Vol. 27

This list was generated on Mon Jul 15 06:30:18 2019 CEST.